FDA official logo
GSRS logo
PFDA official logo

ABCIXIMAB

  • UNII: X85G7936GV
  • Preferred Substance Name: ABCIXIMAB

  • 143653-53-6
  • ABCIXIMAB (GENETICAL RECOMBINATION)
  • ABCIXIMAB (GENETICAL RECOMBINATION) [JAN]
  • ABCIXIMAB [INN]
  • ABCIXIMAB [MART.]
  • ABCIXIMAB [MI]
  • ABCIXIMAB [PURPLE BOOK, CDER]
  • ABCIXIMAB [USAN]
  • ABCIXIMAB [VANDF]
  • ABCIXIMAB [WHO-DD]
  • C7E3
  • IMMUNOGLOBULIN G1, (HUMAN-MOUSE MONOCLONAL C7E3 CLONE P7E3V(SUB H)HC(SUB .GAMMA.1) FAB FRAGMENT ANTI-HUMAN GLYCOPROTEIN IIB/IIIA RECEPTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C7E3 CLONE P7E3V(SUB .KAPPA.)HC(SUB .KAPPA.) LIGHT CHAIN
  • IMMUNOGLOBULIN G1, (HUMAN-MOUSE MONOCLONAL C7E3 CLONE P7E3V(SUB H)HC(SUB .GAMMA.1) FAB FRAGMENT ANTI-HUMAN GLYCOPROTEIN IIB/IIIA RECEPTOR), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL C7E3 CLONE P7E3V(SUB .KAPPA.)HC(SUB .KAPPA.) LIGHT CHAIN
  • MABFRAG CHIMERIC (IGG1) ANTI P08514 (ITA2B_HUMAN) (IBD657)
  • REOPRO

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.